Ferris, R. L., Lenz, H. J., Trotta, A. M., García-Foncillas López, J. M., Schulten, J., Audhuy, F., . . . Milano, G. (2018). Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation.
Citação norma ChicagoFerris, Robert L., Heinz Josef Lenz, Anna Maria Trotta, Jesús Miguel García-Foncillas López, Jeltje Schulten, François Audhuy, Marco Merlano, y Gerard Milano. Rationale for Combination of Therapeutic Antibodies Targeting Tumor Cells and Immune Checkpoint Receptors: Harnessing Innate and Adaptive Immunity Through IgG1 Isotype Immune Effector Stimulation. 2018.
Citação norma MLAFerris, Robert L., et al. Rationale for Combination of Therapeutic Antibodies Targeting Tumor Cells and Immune Checkpoint Receptors: Harnessing Innate and Adaptive Immunity Through IgG1 Isotype Immune Effector Stimulation. 2018.